Moses Nasalo

Christchurch (NZL)
Role(s):
C-Level Executive (CEO, CFO, etc.)

Medical Kiwi

Location: Christchurch
Industry: Pharmaceuticals
Year Founded: 2018
Number Employees: 10-50 people
Business Stage: Growth (not profitable)
Entity Type: Limited Liability Company
Description: Medical Kiwi is New Zealand leading medicinal cannabis company with strong focus on medicinal research and nutraceutical well-being. We are cultivating change with a new formula for health and wellness that blends natural medicine with science to make a positive difference in people’s health outcomes and improve their quality of life. Medical Kiwi is positioned to supply Germany and other European markets with full EU-GMP products with high THC and consistent quality from its state-of-the-art pharmaceutical growing facility in Christchurch, New Zealand. In 2019, Medical Kiwi filed claims on Balaenone and a method for its extraction under the Patents Cooperation Treaty (PCT) (PCT/IB2019/057224). Patent applications are pending in eight individual PCT jurisdictions, including the European Union, the United States, China and New Zealand. Medical Kiwi expects the first of these patents to be granted during 2022-2023.